| 1 | positive regulation of hormone biosynthetic process (GO:0046886) | 9.42587313 |
| 2 | positive regulation of fibroblast migration (GO:0010763) | 8.56202353 |
| 3 | positive regulation of protein sumoylation (GO:0033235) | 7.65450551 |
| 4 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 7.01693230 |
| 5 | positive regulation of hormone metabolic process (GO:0032352) | 6.89142759 |
| 6 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 6.88765062 |
| 7 | positive regulation of glycolytic process (GO:0045821) | 6.85392458 |
| 8 | negative regulation of heart rate (GO:0010459) | 6.74732171 |
| 9 | mRNA cleavage (GO:0006379) | 6.25703499 |
| 10 | mRNA transcription (GO:0009299) | 6.04990554 |
| 11 | regulation of glomerular filtration (GO:0003093) | 6.02985772 |
| 12 | nerve growth factor signaling pathway (GO:0038180) | 5.84321341 |
| 13 | negative regulation of T cell mediated immunity (GO:0002710) | 5.75031605 |
| 14 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 5.61627879 |
| 15 | negative regulation of interleukin-2 production (GO:0032703) | 5.44311412 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 5.05626304 |
| 17 | positive regulation of T cell cytokine production (GO:0002726) | 5.04150253 |
| 18 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.99014020 |
| 19 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.98740952 |
| 20 | cellular response to nerve growth factor stimulus (GO:1990090) | 4.92575869 |
| 21 | response to nerve growth factor (GO:1990089) | 4.92575869 |
| 22 | positive regulation of erythrocyte differentiation (GO:0045648) | 4.80763824 |
| 23 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.79234780 |
| 24 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.77761965 |
| 25 | T-helper cell differentiation (GO:0042093) | 4.77761965 |
| 26 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.64096551 |
| 27 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.64096551 |
| 28 | regulation of protein sumoylation (GO:0033233) | 4.56023611 |
| 29 | cellular response to nicotine (GO:0071316) | 4.54014363 |
| 30 | positive regulation of circadian rhythm (GO:0042753) | 4.49931424 |
| 31 | cellular response to interleukin-4 (GO:0071353) | 4.38396097 |
| 32 | positive regulation of T cell chemotaxis (GO:0010820) | 4.38361348 |
| 33 | regulation of T cell chemotaxis (GO:0010819) | 4.38361348 |
| 34 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.35493239 |
| 35 | positive regulation of granulocyte differentiation (GO:0030854) | 4.35477460 |
| 36 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 4.23981292 |
| 37 | regulation of circadian sleep/wake cycle (GO:0042749) | 4.23981292 |
| 38 | positive regulation of cell killing (GO:0031343) | 4.23938153 |
| 39 | T cell differentiation involved in immune response (GO:0002292) | 4.23293075 |
| 40 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.23293075 |
| 41 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.23293075 |
| 42 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.21720720 |
| 43 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.20590087 |
| 44 | fucose catabolic process (GO:0019317) | 4.19629800 |
| 45 | L-fucose metabolic process (GO:0042354) | 4.19629800 |
| 46 | L-fucose catabolic process (GO:0042355) | 4.19629800 |
| 47 | activated T cell proliferation (GO:0050798) | 4.14398799 |
| 48 | renal system process involved in regulation of blood volume (GO:0001977) | 4.12894840 |
| 49 | positive regulation of T-helper 1 type immune response (GO:0002827) | 4.12773381 |
| 50 | negative regulation of alpha-beta T cell activation (GO:0046636) | 4.09003628 |
| 51 | protein polyglutamylation (GO:0018095) | 3.93636095 |
| 52 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.89587087 |
| 53 | positive regulation vascular endothelial growth factor production (GO:0010575) | 3.89157878 |
| 54 | lymphocyte chemotaxis (GO:0048247) | 3.88503539 |
| 55 | radial glial cell differentiation (GO:0060019) | 3.86202348 |
| 56 | regulation of T cell cytokine production (GO:0002724) | 3.85862856 |
| 57 | response to interleukin-4 (GO:0070670) | 3.83325032 |
| 58 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.81390725 |
| 59 | regulation of cell killing (GO:0031341) | 3.76111657 |
| 60 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.73281410 |
| 61 | regulation of memory T cell differentiation (GO:0043380) | 3.71942034 |
| 62 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.66661748 |
| 63 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.66184824 |
| 64 | regulation of glycolytic process (GO:0006110) | 3.65647186 |
| 65 | positive regulation of type 2 immune response (GO:0002830) | 3.60400577 |
| 66 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.58434825 |
| 67 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.53563933 |
| 68 | regulation of hormone biosynthetic process (GO:0046885) | 3.50447372 |
| 69 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.48269704 |
| 70 | regulation of urine volume (GO:0035809) | 3.47974479 |
| 71 | interkinetic nuclear migration (GO:0022027) | 3.45995601 |
| 72 | positive regulation of response to biotic stimulus (GO:0002833) | 3.45723553 |
| 73 | embryonic placenta development (GO:0001892) | 3.44484603 |
| 74 | response to interleukin-15 (GO:0070672) | 3.44367092 |
| 75 | cellular response to interleukin-15 (GO:0071350) | 3.42551791 |
| 76 | regulation of fibroblast migration (GO:0010762) | 3.39856158 |
| 77 | regulation of superoxide anion generation (GO:0032928) | 3.38297607 |
| 78 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.37558960 |
| 79 | positive regulation of heart rate (GO:0010460) | 3.35620167 |
| 80 | regulation of vascular endothelial growth factor production (GO:0010574) | 3.33514184 |
| 81 | positive regulation by host of viral transcription (GO:0043923) | 3.28667159 |
| 82 | circadian sleep/wake cycle process (GO:0022410) | 3.27012406 |
| 83 | regulation of T-helper 1 type immune response (GO:0002825) | 3.26261850 |
| 84 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 3.23630381 |
| 85 | negative regulation of necroptotic process (GO:0060546) | 3.22563314 |
| 86 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.22411612 |
| 87 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.22355184 |
| 88 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 3.21004054 |
| 89 | regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418) | 3.20261386 |
| 90 | developmental pigmentation (GO:0048066) | 3.20120843 |
| 91 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.15976072 |
| 92 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.15976072 |
| 93 | regulation of renal sodium excretion (GO:0035813) | 3.13791871 |
| 94 | negative regulation of adaptive immune response (GO:0002820) | 3.13699380 |
| 95 | tongue development (GO:0043586) | 3.12946145 |
| 96 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.12724638 |
| 97 | negative regulation of heart contraction (GO:0045822) | 3.12022144 |
| 98 | regulation of RIG-I signaling pathway (GO:0039535) | 11.7222365 |
| 99 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 11.0593164 |
| 100 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 10.3543439 |
TRBV10-2 
